In this episode, we sit down with Brian Keane, a seasoned professional with 25 years of capital markets experience and over $3 billion in investments transacted. Brian’s career spans multiple roles, from advisor and banker at investment banks to co-founder, director, and advisor to dozens of private and public companies in both the USA and Canada. Today, Brian is the Chairman and CEO of DiaGen.ai, a cutting-edge pre-IPO Gen AI company that’s revolutionizing the fields of drug discovery, diagnostics, vaccine development, and precision medicine.

Brian shares his journey from capital markets to the forefront of biotech and AI innovation, explaining how his expertise in investments and technology led him to DiaGen.ai. He also discusses the role Gen AI is playing in transforming the healthcare industry, from speeding up drug development to improving diagnostics and personalized medicine.

Brian’s vast experience in capital markets and his current leadership role in a pioneering Gen AI company make this episode a must-listen for anyone interested in the future of medicine, technology, and investment.

Connect with Brian:

LinkedIn: https://www.linkedin.com/in/brian-d-keane-47b09b2/

DiaGen.ai

QualifiedCap.com

Support the show

Connect with Chris Salerno:
Website: www.qccapitalgroup.com
LinkedIn: Christopher Salerno
Instagram: @chris_salerno_
X (formerly Twitter): @Chris_Salerno_
TikTok: @chris_salerno_